# | Title | Journal | Year | Citations |
---|
1 | An Evidence-Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions | Journal of Addiction Medicine | 2011 | 527 |
2 | American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use | Journal of Addiction Medicine | 2015 | 474 |
3 | A Systematic Review of Community Opioid Overdose Prevention and Naloxone Distribution Programs | Journal of Addiction Medicine | 2014 | 352 |
4 | Food Addiction | Journal of Addiction Medicine | 2009 | 326 |
5 | Statement of the American Society of Addiction Medicine Consensus Panel on the Use of Buprenorphine in Office-Based Treatment of Opioid Addiction | Journal of Addiction Medicine | 2011 | 243 |
6 | A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction | Journal of Addiction Medicine | 2016 | 232 |
7 | Misuse of Novel Synthetic Opioids: A Deadly New Trend | Journal of Addiction Medicine | 2017 | 225 |
8 | A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence | Journal of Addiction Medicine | 2013 | 220 |
9 | Dopamine Genes and Reward Dependence in Adolescents with Excessive Internet Video Game Play | Journal of Addiction Medicine | 2007 | 198 |
10 | Alcohol Consumption in Response to the COVID-19 Pandemic in the United States | Journal of Addiction Medicine | 2021 | 198 |
11 | A Review of Buprenorphine Diversion and Misuse | Journal of Addiction Medicine | 2014 | 196 |
12 | Increased Alcohol Consumption, Nonmedical Prescription Drug Use, and Illicit Drug Use Are Associated With Energy Drink Consumption Among College Students | Journal of Addiction Medicine | 2010 | 176 |
13 | Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis | Journal of Addiction Medicine | 2017 | 169 |
14 | Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact | Journal of Addiction Medicine | 2017 | 162 |
15 | Cocaine and Cognition | Journal of Addiction Medicine | 2014 | 159 |
16 | Adoption and Implementation of Medications in Addiction Treatment Programs | Journal of Addiction Medicine | 2011 | 156 |
17 | Mindfulness Meditation for Alcohol Relapse Prevention: A Feasibility Pilot Study | Journal of Addiction Medicine | 2008 | 155 |
18 | Opioid Use Disorder and COVID-19: Crashing of the Crises | Journal of Addiction Medicine | 2020 | 153 |
19 | Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance | Journal of Addiction Medicine | 2017 | 146 |
20 | Energy Drinks, Soft Drinks, and Substance Use Among United States Secondary School Students | Journal of Addiction Medicine | 2014 | 145 |
21 | The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update | Journal of Addiction Medicine | 2020 | 140 |
22 | The Opioid Dependent Mother and Newborn Dyad: Nonpharmacologic Care | Journal of Addiction Medicine | 2008 | 139 |
23 | Natural Addiction | Journal of Addiction Medicine | 2009 | 136 |
24 | Imaging of Brain Dopamine Pathways | Journal of Addiction Medicine | 2009 | 131 |
25 | Knowledge, Attitudes, and Practice of Electronic Cigarette Use Among Pregnant Women | Journal of Addiction Medicine | 2015 | 131 |
26 | Innovation During COVID-19: Improving Addiction Treatment Access | Journal of Addiction Medicine | 2020 | 129 |
27 | Cross-Validation of a Screener to Predict Opioid Misuse in Chronic Pain Patients (SOAPP-R) | Journal of Addiction Medicine | 2009 | 126 |
28 | Gender Differences in Adolescent Marijuana Use and Associated Psychosocial Characteristics | Journal of Addiction Medicine | 2011 | 125 |
29 | High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System | Journal of Addiction Medicine | 2017 | 125 |
30 | Illicit Use of Buprenorphine/Naloxone Among Injecting and Noninjecting Opioid Users | Journal of Addiction Medicine | 2011 | 119 |
31 | The Case for Chronic Disease Management for Addiction | Journal of Addiction Medicine | 2008 | 115 |
32 | Acute Care Hospital Utilization Among Medical Inpatients Discharged With a Substance Use Disorder Diagnosis | Journal of Addiction Medicine | 2012 | 115 |
33 | Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm | Journal of Addiction Medicine | 2017 | 112 |
34 | Defining Low-threshold Buprenorphine Treatment | Journal of Addiction Medicine | 2020 | 105 |
35 | PATHOS | Journal of Addiction Medicine | 2012 | 102 |
36 | Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System | Journal of Addiction Medicine | 2017 | 102 |
37 | Reasons for Misuse of Prescription Medication Among Physicians Undergoing Monitoring by a Physician Health Program | Journal of Addiction Medicine | 2013 | 96 |
38 | How Do Prescription Opioid Users Differ From Users of Heroin or Other Drugs in Psychopathology: Results From the National Epidemiologic Survey on Alcohol and Related Conditions | Journal of Addiction Medicine | 2011 | 95 |
39 | Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations | Journal of Addiction Medicine | 2019 | 95 |
40 | Gender Differences in Substance Abuse Treatment and Barriers to Care Among Persons With Substance Use Disorders With and Without Comorbid Major Depression | Journal of Addiction Medicine | 2013 | 94 |
41 | Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans | Journal of Addiction Medicine | 2015 | 94 |
42 | The Synthetic Cannabinoid Withdrawal Syndrome | Journal of Addiction Medicine | 2013 | 93 |
43 | Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis | Journal of Addiction Medicine | 2017 | 92 |
44 | Screening and Brief Intervention for Unhealthy Drug Use in Primary Care Settings: Randomized Clinical Trials Are Needed | Journal of Addiction Medicine | 2010 | 90 |
45 | Gambling During the COVID-19 Crisis – A Cause for Concern | Journal of Addiction Medicine | 2020 | 88 |
46 | Appropriate Use of Drug Testing in Clinical Addiction Medicine | Journal of Addiction Medicine | 2017 | 86 |
47 | A Review of Alprazolam Use, Misuse, and Withdrawal | Journal of Addiction Medicine | 2018 | 86 |
48 | Science and Electronic Cigarettes | Journal of Addiction Medicine | 2014 | 81 |
49 | Methadone and Buprenorphine for Opioid Dependence During Pregnancy | Journal of Addiction Medicine | 2015 | 80 |
50 | Role of the Hospital in the 21st Century Opioid Overdose Epidemic: The Addiction Medicine Consult Service | Journal of Addiction Medicine | 2019 | 78 |